PCK 3.85% 2.7¢ painchek ltd

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2

  1. 1,250 Posts.
    lightbulb Created with Sketch. 232
    Probably the best quarterly I've seen for painchek. Although I got it wrong with the FDA timelines. Clinical trial hasn't even started yet. Forecast to begin Q4 CY22. Sales in NZ,Scotland,England,Wales and 60% of RACs in Australia. So much to look forward to! $585k receipts from customers for the qtr. The growth continues. Very positive.
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
0.001(3.85%)
Mkt cap ! $44.16M
Open High Low Value Volume
2.6¢ 2.7¢ 2.6¢ $18.43K 695.5K

Buyers (Bids)

No. Vol. Price($)
3 347001 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 415999 5
View Market Depth
Last trade - 13.24pm 19/06/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.